Evidence map›Paper›PMID 21441493›Full record

ArticleAdvances in dental research2011

Innate immunity including epithelial and nonspecific host factors: workshop 1B.

A Weinberg, J R Naglik, A Kohli, S M Tugizov, P L Fidel, Y Liu, M Herzberg

Open access · greenAbstract read
In one paragraph

Article in Advances in dental research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Viral Infections During Pregnancy: The Big Challenge Threatening Maternal and Fetal Health.Maternal-fetal medicine (Wolters Kluwer Health, Inc.) · 2022
    Article
  2. Article
  3. Oral innate immunity in HIV infection in HAART era.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2016
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

A WeinbergCase Western Reserve University, Cleveland, Ohio, USA.
J R Naglik
A Kohli
S M Tugizov
P L Fidel
Y Liu
M Herzberg
King's College London · GBCase Western Reserve University · USLouisiana State University · USPeking University · CNUniversity of California, San Francisco · USUniversity of Minnesota · US

Funding

EBV BMRF-2 Protein in Infection of Oral Epithelial CellsR01DE014894 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TUGIZOV, SHAROF M · 2003 to 2007
$1.5M
The oral mucosal proteome: perturbation in HIV infection and Candida co infectionR01DE017514 · NIDCR · KING'S COLLEGE LONDON · PI CHALLACOMBE, STEPHEN J · 2006 to 2010
$1.3M
NIDCR NIH HHS R01 DE014894NIDCR NIH HHS R01 DE017514
6 · The paper itself

Abstract

The majority of HIV infections are initiated at mucosal sites. The oral mucosal tissue has been shown to be a potential route of entry in humans and primates. Whereas HIV RNA, proviral DNA, and infected cells are detected in the oral mucosa and saliva of infected individuals, it appears that the oral mucosa is not permissive for efficient HIV replication and therefore may differ in susceptibility to infection when compared to other mucosal sites. Since there is no definitive information regarding the fate of the HIV virion in mucosal epithelium, there is a pressing need to understand what occurs when the virus is in contact with this tissue, what mechanisms are in play to determine the outcome, and to what degree the mechanisms and outcomes differ between mucosal sites. Workshop 1B tackled 5 important questions to define current knowledge about epithelial cell-derived innate immune agents, commensal and endogenous pathogens, and epithelial cells and cells of the adaptive immune system and how they contribute to dissemination or resistance to HIV infection. Discovering factors that explain the differential susceptibility and resistance to HIV infection in mucosal sites will allow for the identification and development of novel protective strategies.

Indexed as

Immunity, InnateAnimalsCytokinesDefensinsDendritic CellsEpithelial CellsFemaleFocus GroupsHIV-1HIV InfectionsHumansImmunity, MucosalLeukocytesMaternal-Fetal ExchangeMouth MucosaPregnancyCytokinesDefensinsSecretory Leukocyte Peptidase Inhibitor

Identifiers

PMID21441493
PMCPMC6699119
OpenAlexW2052302657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.